None (None)
- Conditions
- depressive states
- Registration Number
- jRCT1032230427
- Lead Sponsor
- None
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 60
(1) Age between 12 and 18 years old at the time of registration
(2) Person on the waiting list at the Department of Child Psychiatry, Yokohama City University Hospital
(3) Persons with self-administered depression rating scale PHQ-9>=10 (moderate or higher depression)
(4) Persons who have a terminal environment that can run the mental self-care application "emol".
(5) Those who are able to use Zoom for online interviewing
(6) Those who have no difficulty in reading and writing Japanese at the upper elementary school level.
(7) Those who can agree not to use other mental self-care applications.
(8) Persons who can obtain written or electromagnetic consent from their parents or guardians and the research subjects to te in this stuparticipady.
(1) Those with a high degree of urgency as judged by a child psychiatrist (those deemed appropriate to be seen within 8 weeks)
(2) Those who have reported suicide attempts within the past 2 weeks on the medical questionnaire.
(3) Those who have anorexia and have an imminent need for physical treatment.
(4) No plans for psychiatric consultation or counseling during the intervention period.
(5) Those who continue to take psychotropic drugs prescribed by the above-mentioned medical institutions.
(6) Those who have difficulty in keeping a daily log due to an injury to their dominant hand.
(7) Other persons who are judged to be unsuitable for the program by the physician.
Study & Design
- Study Type
- Interventional
- Study Design
- parallel assignment
- Primary Outcome Measures
Name Time Method - Change in PHQ-9 before and after intervention
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.